This Project Grant award of $379,394 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to uncover the molecular mechanisms behind hydrogen peroxide (H2O2)-mediated protein regulation. The research plan includes four key projects: 1) identifying proteins directly oxidized by high H2O2 levels that activate and deactivate specific transcription factors and kinases, 2) using proteomics to map...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $248,999 to the University of North Carolina at Chapel Hill to conduct research on the regulation of oxidative stress signaling by tyrosine phosphorylation of antioxidant enzymes. The goal is to gain network-level insight into how obesity-driven tyrosine phosphorylation modulates the activity of antioxidant enzymes, leading to...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $447,337 to Ball State University to conduct research on the regulator MITONEET and its role in cellular redox homeostasis and signaling. The research aims to investigate how the electronic properties and stability of the MITONEET [2Fe-2S] cluster contribute to the metabolism of sulfur-containing molecules and the...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA Program 93.310 - Trans-NIH Research Support, provides $1,476,000.00 to The University of Texas Southwestern Medical Center to develop and apply innovative tools to study the role of subcellular redox circuits in tumor metastasis. The project aims to address key questions about how highly metastatic tumors overcome oxidative stress, using advanced in vivo optogenetic approaches,...
This Project Grant award, ID R35GM156443, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The $419,375 award, spanning January 1, 2025 to November 30, 2029, supports research at the University of New Mexico Health Sciences Center (UNM HSC) to define the functional dynamics of multidomain redox enzymes, with a focus on nitric oxide synthase (NOS) enzymes. The research aims to gain a comprehensive...
This $222,852 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to computationally assess the impact of aging-related oxidative stress on the human proteome using a novel deep learning methodology. The project will construct a deep learning-based atomic protein structure embedding method to predict the likelihood of oxidation-related modifications occurring across the entire human proteome. The...
The National Institute of General Medical Sciences (NIGMS) awarded a $647,301 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the Massachusetts Institute of Technology (MIT) to advance the understanding of iron-sulfur enzyme mechanisms. The 5-year project aims to develop synthetic models of iron-sulfur clusters and new spectroscopic methods to better characterize the structure and reactivity of iron-sulfur enzymes, which are critical for human health...
This Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research into the physiology of oxidative stress in bacteria. The total funding amount is $761,271.00, awarded from July 1, 2025 through June 30, 2030. The research aims to detail the threats that oxygen poses to bacteria, the defensive mechanisms they have evolved, and the situations in which oxidative stress...
This $1,031,595 project grant from the National Institute on Aging, part of the Department of Health and Human Services, supports research under the Aging Research program (CFDA 93.866). The awardee, Dana-Farber Cancer Institute, will define the landscape and mechanisms of protein redox regulation during aging. Specifically, the Institute will systematically map cysteine oxidation networks in mouse tissues to determine their role in coordinating protein complex assemblies relevant to age-related...
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), awarded a $260,940 Project Grant to The Regents of the University of California, operating as Lawrence Berkeley National Laboratory (LBNL). The goal of this 2.5-year award, with a period of performance from July 2025 to February 2028, is to develop new X-ray absorption spectroscopy (XAS) methods that can utilize ultra-short, femtosecond X-ray pulses from X-ray...
REDOX REGULATION OF PROTEIN KINASE FUNCTION: BIOCHEMICAL MECHANISMS AND CELLULAR CONSEQUENCES - SUMMARY. MY RESEARCH PROGRAM FOCUSES ON UNDERSTANDING THE ORGANIZATION AND REGULATION OF PHOSPHORYLATION-DEPENDENT SIGNALING NETWORKS IN HEALTH AND DISEASE. IN PARTICULAR, WE ARE INTERESTED IN DECIPHERING THE BIOCHEMICAL AND CELLULAR MECHANISMS OF CROSSTALK BETWEEN PHOSPHORYLATION-DEPENDENT SIGNALING AND OTHER SIGNALING PATHWAYS AT THE LEVEL OF POSTTRANSLATIONAL MODIFICATION OF PROTEIN KINASES. ONE ATTRACTIVE MODIFICATION IS REVERSIBLE OXIDATION, MEDIATED BY REACTIVE OXYGEN SPECIES (ROS). ROS ARE EMERGING AS CRITICAL SECOND MESSENGERS IN SIGNALING PATHWAYS RELATED TO MANY PERVASIVE DISEASES, INCLUDING DIABETES, CANCER, AND CARDIOVASCULAR DISEASE. A GROWING BODY OF EVIDENCE SUGGESTS THAT PROTEIN KINASES ARE DIRECTLY REGULATED BY REDOX MODIFICATIONS. FOR INSTANCE, THE REVERSIBLE OXIDATION OF CYS RESIDUES IN REDOX-SENSITIVE KINASES HAS BEEN SHOWN TO INFLUENCE THEIR ACTIVITY (BOTH POSITIVELY AND NEGATIVELY), SUBCELLULAR LOCALIZATION, AND PROTEIN-PROTEIN INTERACTIONS. IN MANY CASES, THE MODIFIED CYS IS CONSERVED AMONG OTHER MEMBERS IN THE SAME KINASE FAMILY. THIS RAISES THE INTRIGUING POSSIBILITY THAT REVERSIBLE OXIDATION MAY BE A GENERAL MEANS OF REGULATING KINASE FUNCTION INSIDE CELLS. TO EXPLORE THIS POSSIBILITY FURTHER, WE ARE EXAMINING THE IMPACT OF H2O2-DEPEDENT OXIDATION ON THE GLOBAL SUBSTRATE SELECTION OF SEVERAL MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND AGC FAMILY MEMBERS USING FUNCTIONAL PROTEIN MICROARRAYS AND COMPLEMENTARY BIOCHEMICAL, BIOPHYSICAL, MUTATIONAL, COMPUTATIONAL, AND CELL-BASED STRATEGIES. OUR DATA SUGGEST THAT H2O2-DEPENDENT OXIDATION SHIFTS THE SUBSTRATE PREFERENCE OF MANY KINASES, LEADING TO DISTINCT SUBSTRATE PROFILES IN THE OXIDIZED AND REDUCED STATES. FOR INSTANCE, WITH SUPPORT OF AN NIGMS SC1 AWARD (5SC1GM130545), WE ARE CURRENTLY STUDYING THE BIOCHEMICAL MECHANISMS UNDERLYING THE H2O2-INDUCED SHIFTS IN THE SUBSTRATE SELECTION OF THE CANONICAL AGC AND MAPK FAMILY MEMBERS, PKA-CA AND ERK2. THESE STUDIES SUGGEST THAT REVERSIBLE OXIDATION OF PKA-CA AND ERK2 INCREASES THEIR AFFINITY FOR SOME SUBSTRATES WHILE DECREASING OR HAVING LITTLE EFFECT ON OTHERS. INTERESTINGLY, DIFFERENT TYPES OF REDOX MODIFICATION (E.G., DIAMIDE-MEDIATED OXIDATION, H2O2-DEPENDENT OXIDATION, OR GLUTATHIONYLATION) LED TO DIFFERENT ACTIVITY PROFILES TOWARD THE SAME MODEL SUBSTRATES. WITH SUPPORT FROM THE PROPOSED MIRA, WE PROPOSE TO BUILD ON THESE STUDIES BY ASKING QUESTIONS ABOUT 1) THE EFFECTS OF REDOX MODIFICATION OF KINASE SUBSTRATE SELECTION IN VARIOUS CELLULAR CONTEXTS AND THEIR IMPACT ON SIGNALING OUTCOMES RELATED TO DISEASE; 2) THE IMPACT OF REDOX MODIFICATION ON THE SPATIOTEMPORAL REGULATION OF KINASE ACTIVITY PROFILES IN CELLS; AND 3) HOW THE GLOBAL SUBSTRATE PROFILES OF OTHER PROTEIN KINASES, INCLUDING UNDERSTUDIED KINASES IN THE "DARK KINOME", ARE AFFECTED BY H2O2-DEPENDENT OXIDATION AND/OR DIFFERENT TYPES OF REDOX MODIFICATIONS. TOGETHER, THESE STUDIES WILL OFFER UNIQUE INSIGHTS INTO MECHANISMS OF CROSSTALK BETWEEN REDOX- AND PHOSPHORYLATION- DEPENDENT SIGNALING PATHWAYS IN PHYSIOLOGICAL & PATHOLOGICAL PROCESSES. IMPORTANTLY, A MIRA WILL ALSO FACILITATE MENTORING OF TRAINEES FROM UNDERREPRESENTED MINORITY GROUPS, PROMOTING DIVERSITY OF THE BIOMEDICAL WORKFORCE.